Latest "Convoy for a Cure" News Stories

01:30 EDT 25th March 2018 | BioPortfolio

Here are the most relevant search results for "Convoy for a Cure" found in our extensive news archives from over 250 global news sources.

More Information about Convoy for a Cure on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Convoy for a Cure for you to read. Along with our medical data and news we also list Convoy for a Cure Clinical Trials, which are updated daily. BioPortfolio also has a large database of Convoy for a Cure Companies for you to search.

Showing "Convoy Cure" News Articles 1–25 of 837

Friday 23rd March 2018

Pfizer: swallowing hard

Failure to sell its consumer healthcare unit has left pharma group looking for a cure

Spark Therapeutics Inc ONCE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummarySpark Therapeutics Inc Spark is a clinicalstage gene therapy company which provides gene therapies for inherited retinal diseases IRDs, neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPKRPE65, SPKCHM, rhonova, LHON, SPKFIX, SPKFVIII and SPKTPP1. The company's gene therapy vectors used in its programs are engineered using adenoassociated virus. Spark's S...

CURE Media Group Announces the 2018 Ovarian Cancer Heroes™

The celebration recognizes individuals who have made exceptional contributions to improving the lives of people affected by ovarian cancer CURE Media Group, the nation’s leading consumer digital and print media enterprise focused entirely on patients with cancer, will honor four individuals who have made a difference in the field of ovarian cancer to...

OncLive® to Focus on Breast Cancer for its Latest State of the Science Summit™

Featured speakers will be breast cancer experts from distinguished medical institutions OncLive®, the leading digital provider of resources and information to oncology professionals, announces State of the Summit Science™: Breast Cancer, which will take place on March 29 at the Hilton Tampa Downtown in Tampa, Florida, from 5:30 to 9:00 p.m. The ...

Auris Health Unveils the FDA-Cleared Monarch Platform, Ushering in a New Era of Medical Intervention

Company’s First Application of Its Innovative Flexible Robotics Platform Is Bronchoscopy Auris Health, Inc. ("Auris Health"), formerly known as Auris Surgical Robotics, Inc., today announced U.S. Food and Drug Administration (FDA) clearance of the company’s Monarch™ Platform, ushering in a new era of medical intervention. This press release...

Scores of Russian diplomats set to be expelled after EU leaders agree Russia 'highly likely' to have carried out Salisbury attack

Scores of Russian diplomats look set to be expelled from European capitals as ten EU countries indicated they were preparing to follow Theresa May's lead in the wake of the Salisbury attacks. France, Poland, Ireland, Croatia, the Czech Republic, Lithuania, Latvia, Denmark, Estonia and the Netherlands are all in discussions about deporting suspected spies after Theresa May shared intelligenc

Thursday 22nd March 2018

Curetis NV CURE Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryCuretis NV Curetis is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, implant and tissue infections; and in the laboratory for multiplex polymerase chain reaction pcr diagnost...

New Centre Could Revolutionise Treatment of Incurable Diseases

A new centre will be set up in Newcastle to look at the development of cell, gene and tissue engineered therapies in the UK. University and Newcastle Hospitals NHS Foundation Trust have been awarded one of three Advanced Therapies Treatment Centres that could revolutionise the management of incurable diseases. The Northern Alliance Advanced Therapies Treatment Centre will bring together universit...

Older adults who have slower walking speeds may have increased risk for dementia

(American Geriatrics Society) Because there's currently no cure for dementia, it's important to know about risk factors that may lead to developing it. For example, researchers have learned that older adults with slower walking speeds seem to have a greater risk than those with faster walking speeds. Recently, researchers from the UK. teamed up to learn more about changes in walking speed, changes...

CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies

LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will participate in an educational panel about cannabis science in Hawaii. This “Dinner & Dialogue” is put on by Lua Ola, Hawaii’s leading medical cannabis provider, and will address ho...

CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ

OXNARD, Calif., March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that it secured a $1 million bridge financing from accredited investors for working capital and the potential uplisting to NASDAQ. Alexander Capital, LP acted as the sole placement agent for the transaction. “This capital raise takes us t...

Your Grilled Burger May Come with a Side of High Blood Pressure – Live Science

Live ScienceYour Grilled Burger May Come with a Side of High Blood PressureLive ScienceBad news for barbecue lovers: Regularly eating meats that are sizzled on the grill may increase the risk of high blood pressure, a new study suggests. Other high-temperature cooking methods, including broiling and roasting, were also linked with high ...Could grilling your meat raise blood pressure?Medical News ...

vTv Therapeutics Announces Completion of Phase 1b Study Evaluating TTP399 for the Treatment of Type 1 Diabetes

Simplici-T1 is an adaptive Phase 1b/2 study being conducted with support from JDRF vTv Therapeutics Inc. (Nasdaq: VTVT) today announced the completion of Phase 1b of Simplici-T1, an adaptive Phase 1b/2 study assessing the pharmacokinetics, pharmacodynamics, safety and tolerability of TTP399 in adult patients with type 1 diabetes (T1D). The study...

Biomedical Group Brings California’s Regenerative Medicine Research to the National Stage

Biocom, the association representing the life science industry of California, concluded its Regenerative Medicine Advocacy Fly-In to Washington, D.C. yesterday, the culmination of almost a year of efforts to elevate the voice of California’s regenerative medicine community. Regenerative medicine is an emerging field of research that is pioneerin...

Society for Immunotherapy of Cancer Announces 2018 Recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship

The Society for Immunotherapy of Cancer (SITC) is pleased to announce Philip D. Greenberg, MD, Head of the Program in Immunology at Fred Hutchinson Cancer Research Center and University of Washington Professor of Medicine (Oncology) and Immunology, as the 2018 recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship, the society’s highest honor. MILWAUKEE (PRWEB) March 22, 2018 T...

Zyris, Inc. Announces the New Isolite 3, the First Dental Isolation System to Include Both White and a True, Cure-Safe Amber Light for Intra-Oral Illumination

Zyris, Inc., the industry leader in dental isolation technology, today announced the new Isolite 3 dental isolation system. The new Isolite 3 allows dentists to quickly and easily implement a standard protocol for consistent outcomes in procedures that benefit from and require moisture control and isolation. ATLANTA (PRWEB) March 22, 2018 Zyris, Inc., the industry leader in dental isolation techn...

Hamas kills man wanted in attack on Palestinian PM

GAZA CITY, Gaza Strip (AP) — A man wanted for a bombing that targeted the Palestinian premier's convoy as he visited Gaza last week was killed in a firefight Thursday with Hamas forces, the militant Islamic group that rules the territory said.

Wednesday 21st March 2018

CURE Media Group Launches Weekly Podcast

CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, has launched its new weekly podcast, “CURE® Talks Cancer.” The podcast includes interviews with patients, survivors, caregivers, advocates and health care professionals regarding the entire cancer continuum, including specific can...

Tuesday 20th March 2018

Drugs to vaccinate over-50s against Alzheimer’s could be here in a decade…with a £ 9bn price tag – to vaccinate over-50s against Alzheimer's could be here in a decade...with a £ 9bn price to vaccinate everyone over the age of 50 against Alzheimer's could be available within 10 years, but would cost the NHS £9 billion, a new report has shown. New analysis commissioned by Alzheimer's Research UK found that drugs to halt, slow or ...Start savi...

Patients regain sight after treatment with retinal tissue from stem cells

Patients with sudden severe sight loss from wet AMD have regained reading vision after being implanted with an engineered patch of retinal pigment epithelium cells derived from stem cells.The study, conducted by the London Project to Cure Blindness, investigated whether a stem cell based patched could replenish diseased cells at the back of a patient’s affected eye. Two patients with the severe ...

OncLive® to Host Webinar on Emerging Strategies for Treatment of BRCA-Mutated Breast Cancer

Featured faculty will deliver latest updates in the management of breast cancer OncLive®, the leading digital provider of resources and information for oncology professionals, will present the webinar, “Emerging Strategies for Treatment of BRCA-Mutated Breast Cancer,” on March 29 at 2 p.m. EDT. “We are thrilled to host this live-feed we...

Patients with severe wet AMD regain vision after stem cell treatment

Two patients with very severe wet age related macular degeneration (AMD) who received stem cell treatment have regained reading vision.The findings, from a phase I trial by the London Project to Cure...

Science Magazine Recognizes Frequency Therapeutics’ PCA Regeneration Technology as a Breakthrough in Regenerative Medicine

Frequency Co-founder Will McLean, Ph.D., Named a Finalist Awardee for the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy Frequency Therapeutics, a biotechnology company spearheading the move

USS Juneau discovered: The five brothers who went down together with the sunken battleship  

The USS Juneau is the latest Second World War wreck to be discovered by a team funded by billionaire Microsoft co-founder, Paul Allen. The discovery on March 17 locates another mass grave of American servicemen, as only 10 of its almost 700-strong crew survived its sinking during the Battle of Guadalcanal in 1942. Among the hundreds who went down with the ship were five brothers, the Sullivans, wh...

Monday 19th March 2018

Can Gilead Develop a Cure for HIV?

Gilead Sciences essentially created a cure for hepatitis C and may be well on its way to developing a cure for HIV-AIDS.

Quick Search


News Quicklinks